Answer
Trixeo Aerosphere should only be considered during breastfeeding if the expected maternal benefit exceeds any possible risk to the child; budesonide enters breast milk but no infant effects are anticipated at therapeutic doses, while human milk excretion of glycopyrronium and formoterol is unknown.
Sources for this answer
- Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspensionAstraZeneca UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked